Koers Escalon Medical Corp. Nasdaq
Aandelen
US2960743050
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 10,7 mln. 9,95 mln. | Omzet 2023 | 12,18 mln. 11,32 mln. | Marktkapitalisatie | 1,85 mln. 1,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 0,14 x |
Nettoschuld 2022 | 611K 568K | Nettoschuld 2023 | 205 190,5 | EV/omzet 2023 | 0,15 x |
K/w-verhouding 2022 |
-28
x | K/w-verhouding 2023 |
8,37
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 01-11-00 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 01-01-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 01-01-03 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 01-11-00 |
David Jacovini
BRD | Director/Board Member | 48 | 13-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,84% | 218 mld. | |
+7,35% | 184 mld. | |
+13,04% | 135 mld. | |
+26,03% | 107 mld. | |
-1,33% | 62,38 mld. | |
+11,80% | 51,37 mld. | |
+4,81% | 50,9 mld. | |
+0,30% | 40,87 mld. | |
+2,78% | 36,28 mld. |